Cadre (CDRE) Set to Announce Quarterly Earnings on Tuesday

Cadre (NYSE:CDRE) will post its quarterly earnings results after the market closes on Tuesday, May 7th. Analysts expect Cadre to post earnings of $0.25 per share for the quarter. Parties interested in registering for the company’s conference call can do so using this link.

Cadre (NYSE:CDRE) last posted its quarterly earnings results on Tuesday, March 5th. The company reported $0.29 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.18 by $0.11. The business had revenue of $124.58 million for the quarter, compared to analysts’ expectations of $122.30 million. Cadre had a return on equity of 21.85% and a net margin of 8.01%. On average, analysts expect Cadre to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Cadre Stock Performance

Shares of NYSE:CDRE opened at $34.19 on Monday. The stock has a market capitalization of $1.39 billion, a P/E ratio of 33.52, a P/E/G ratio of 1.80 and a beta of 1.35. The company has a current ratio of 2.58, a quick ratio of 1.73 and a debt-to-equity ratio of 0.65. Cadre has a 1-year low of $19.13 and a 1-year high of $39.81. The business has a 50-day moving average price of $35.22 and a two-hundred day moving average price of $33.31.

Cadre Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 17th. Investors of record on Friday, May 3rd will be paid a dividend of $0.0875 per share. This represents a $0.35 dividend on an annualized basis and a dividend yield of 1.02%. The ex-dividend date of this dividend is Thursday, May 2nd. Cadre’s dividend payout ratio (DPR) is 34.31%.

Analysts Set New Price Targets

Several brokerages have commented on CDRE. Stephens upped their target price on shares of Cadre from $36.00 to $40.00 and gave the company an “overweight” rating in a research report on Friday, February 16th. B. Riley reiterated a “buy” rating and issued a $48.00 price objective (up previously from $40.00) on shares of Cadre in a report on Wednesday, March 6th. Roth Mkm restated a “buy” rating and set a $43.00 target price (up previously from $38.00) on shares of Cadre in a report on Wednesday, March 6th. Raymond James cut Cadre from an “outperform” rating to a “market perform” rating in a research note on Monday, January 22nd. Finally, Stifel Nicolaus increased their price target on shares of Cadre from $33.00 to $34.00 and gave the company a “hold” rating in a research report on Wednesday, March 6th. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $41.25.

Insider Transactions at Cadre

In other Cadre news, CEO Warren B. Kanders sold 1,438,127 shares of the company’s stock in a transaction that occurred on Tuesday, March 19th. The stock was sold at an average price of $35.00, for a total value of $50,334,445.00. Following the sale, the chief executive officer now owns 12,184,918 shares in the company, valued at $426,472,130. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 49.20% of the stock is owned by company insiders.

About Cadre

Cadre Holdings, Inc manufactures and distributes safety that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products.